CBC (Cannabichromene): What It Is and What Is Known
CBC (cannabichromene) is a minor cannabinoid. Read what it is, what mouse and lab studies suggest, and why human evidence and safety data are missing.
Content last updated . This page has not been medically reviewed.
Overview and classification
CBC (cannabichromene) is a minor cannabinoid from the cannabis plant. In this library "CBC" means the cannabis compound; the same letters are also the common abbreviation for a blood test (complete blood count). CBC the cannabinoid is made from the shared precursor CBGA, using its own enzyme, CBCA synthase. [1] Its acid form is CBCA. [2]Evidence labels used on this page: preclinical (cells/animals only), insufficient evidence, marketing claim.
Where it comes from and its chemistry
CBC occurs in the plant independent of the genetic locus (chemotype locus B) that controls THC versus CBD content. [3] A research team found that natural CBC occurs as a mix of two mirror-image forms (enantiomers) in a ratio that depends on the cultivar, and that the biological profile of each form should be studied separately. [4] This matters because a study of one CBC sample may not describe another. See cannabinoids explained.What research shows
| Question | Label | What the sources say |
|---|---|---|
| Pain (acute and nerve-related) | preclinical (cells/animals only) | In naive and neuropathic male and female mice, CBC reduced pain-related behaviors in several tests, including nerve-related pain sensitivity. [5] A broader review reports modest analgesic properties in rodents. [3] |
| Antibacterial and anti-seizure activity | preclinical (cells/animals only) | A 2024 review names pain relief, antibacterial and anti-seizure activity as the areas examined, and says preliminary studies warrant further investigation. [6] |
| Cancer cells and neural stem cells | preclinical (cells/animals only) | Cell studies report effects on tumor cells and on neural stem progenitor cells. [3] |
| Any condition in people | insufficient evidence | The pharmacokinetics review says the biggest gap for CBC and its acid is clinical investigation. [7] |
Proper evidence not found for benefit or safety in people. We checked PubMed for CBC reviews, mouse studies and pharmacokinetics; none reported a human clinical outcome. Do not read mouse results as human results.
Marketing claims and quality
The 2024 review notes that CBC products are sold over the counter and widely used with little or no evidence of safety or efficacy. [6] Claims about mood, pain or energy on CBC products are marketing claims. Content varies between products and batches, so a verified certificate of analysis matters; see product quality and certificates of analysis and minor cannabinoids at a glance.Regulatory category (United States, read 2026-10-22)
The FDA says it has not approved a marketing application for cannabis for any disease or condition. [8] The FDA quotes the 2018 Farm Bill definition of hemp as the plant and its derivatives, cannabinoids, isomers and acids with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis. [8] The Congressional Research Service reports that definition is being amended to total THC, with portions delayed to December 11, 2026. [9] No CBC-specific rule was verified, and other countries and states were not checked. Laws change, and this is not legal advice. See cannabis and CBD laws by country.Safety and special groups
Human safety data for CBC was not found. People who are pregnant, are breastfeeding, have liver or heart conditions, or take regular medicines should check with a clinician; see medication interactions. Keep products away from children; in the US, call Poison Help at 1-800-222-1222 or 911 in an emergency.Frequently asked questions
What is CBC (cannabichromene)?
A minor cannabinoid the plant makes from CBGA. [1]
Does CBC get you high?
No study read for this page tested whether CBC produces intoxication in people, so this is not established. Proper evidence not found.
Does CBC help with pain or inflammation?
Mouse and lab studies suggest pain-related effects. [5] [3] Human evidence is missing. [7]
Is CBC legal?
It depends on the place and product; see the US summary above and the laws page. This is not legal advice.
References
- Domenech et al. X-ray crystal structures of the cannabinoid synthases CBCAS, CBDAS and THCAS. Current Research in Structural Biology. 2026. PubMed abstract read 2026-10-22.
- Singh et al. Therapeutic potential of acidic cannabinoids: an update. Journal of Cannabis Research. 2026. PubMed abstract read 2026-10-22.
- Zagožen, Čerenak and Kreft. Cannabigerol and cannabichromene in Cannabis sativa L.. Acta Pharmaceutica. 2021. PubMed abstract read 2026-10-22.
- Calcaterra et al. Natural Cannabichromene (CBC) Shows Distinct Scalemicity Grades and Enantiomeric Dominance in Cannabis sativa Strains. Journal of Natural Products. 2023. PubMed abstract read 2026-10-22.
- Raup-Konsavage et al. Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests. Biomedicines. 2023. PubMed abstract read 2026-10-22.
- Sepulveda et al. The Potential of Cannabichromene (CBC) as a Therapeutic Agent. Journal of Pharmacology and Experimental Therapeutics. 2024. PubMed abstract read 2026-10-22.
- Lacerda et al. Pharmacokinetics of Non-Psychotropic Phytocannabinoids. Pharmaceutics. 2025. PubMed abstract read 2026-10-22.
- US Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD): Questions and Answers. Read 2026-10-22.
- Congressional Research Service. Changes to the Statutory Definition of Hemp and Implications for Agricultural Policy (CRS In Focus IF13136), updated September 28, 2026. Read 2026-10-22.